The BAG3 Knockout A-549 Polyclonal Cells product provides a CRISPR/Cas9-edited polyclonal knockout cell population derived from human A-549 lung adenocarcinoma epithelial cells. This loss-of-function model is designed to disrupt BAG3 gene expression, enabling rigorous investigation of BAG3-dependent cellular processes. The polyclonal composition offers a heterogeneous knockout pool, facilitating population-level functional analyses without the clonal biases inherent in single-cell-derived lines. This product serves as a versatile tool for studying autophagy, apoptosis, and protein quality control in a cancer-relevant context.
The A-549 cell line originates from a 58-year-old Caucasian male with lung adenocarcinoma and is widely employed as a model system for human lung adenocarcinoma biology, cancer research, and drug screening. These epithelial cells retain key oncogenic features, including aberrant signaling pathways and stress response mechanisms, making them particularly suitable for examining tumor cell survival mechanisms. Their robust growth characteristics and well-characterized molecular profile facilitate reproducible experimental workflows across laboratories.
BAG3 encodes a co-chaperone protein that interacts with HSP70 and HSPB8 to direct misfolded proteins toward autophagic degradation via the chaperone-assisted selective autophagy (CASA) pathway. Additionally, BAG3 binds BCL2 to suppress apoptosis, thereby promoting cell survival under proteotoxic stress. Upstream regulatory inputs include HSF1- and NF-??B-mediated transcriptional activation, triggered by cellular stressors such as heat shock and oxidative stress. Downstream effectors modulated by BAG3 include HSP70, BCL2, LC3, CHIP, and YAP, which collectively coordinate protein quality control and cell fate decisions. BAG3 also interacts with dynein and 14-3-3 proteins, linking the aggresome-autophagy machinery to retrograde transport and phospho-signaling networks.
Disruption of BAG3 in A-549 cells compromises the CASA pathway and releases BCL2-mediated apoptotic restraint, sensitizing these cancer cells to proteotoxic and therapeutic stress. This knockout model permits dissection of BAG3??s role in maintaining protein homeostasis and survival in lung adenocarcinoma. Researchers can employ this system to explore mechanisms of acquired drug resistance, as BAG3 upregulation has been associated with chemoresistance in various cancers. Moreover, the interplay between BAG3-regulated autophagy and apoptosis can be systematically interrogated to identify vulnerabilities that may be exploited therapeutically.
Typical applications include quantitative analysis of autophagy flux using LC3-based assays, apoptosis measurements via caspase 3/7 activation or annexin V staining, and cell viability assessments under endoplasmic reticulum or oxidative stress. The knockout cells are suited for western blotting and RT-qPCR verification of BAG3 ablation, as well as co-immunoprecipitation experiments to examine HSP70/BAG3 complex disruption. Drug sensitivity screens and migration assays further extend the functional readouts. For further information regarding product specifications, lot-to-lot variability, or customized services, please contact Ascent Research.
